Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04043871
Other study ID # IDIL/2018/APM-02
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 5, 2019
Est. completion date August 14, 2019

Study information

Verified date May 2019
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators hypothesize that the Systolic Foot-to-Apex Time Interval (SFATI) method will be accurate for measurement of systolic blood pressure with marked arterial stiffness as seen in patients with severe renal impairment. Also that the presence of arterial calcifications only changes the agreement between the SFATI method and the reference method (auscultatory method) if the calcifications are very severe.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date August 14, 2019
Est. primary completion date August 14, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must have given their free and informed consent and signed the consent form

- The patient must be a member or beneficiary of a health insurance plan

- Patient under consultation in the Nephrology for severe renal impairment (defined by a glomerular filtration rate <30 mL / min, assessment within previous 3 months)

Exclusion Criteria:

- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study

- The subject refuses to sign the consent

- It is impossible to give the subject informed information

- The patient is under safeguard of justice or state guardianship

- Patient is pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Systolic blood pressure
Systolic blood pressure measured by Foot-to-Apex Systolic Interval, conventional oscillometric measurement, and the auscultatory method

Locations

Country Name City State
France CHU de Nimes Nîmes

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes Technology Transfer Accelerator Offices _ SATT AxLR

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic blood pressure according to oscillometric curve mmHg measured by Systolic Foot-to-Apex Time Interval Day 0
Primary Systolic blood pressure according to Korotkov sounds mmHg measured by auscultatory method Day 0
Secondary Brachial pulse wave velocity m/s Day 0
Secondary Systolic blood pressure according to conventional oscillometric measurement mmHg; Dinamap Day 0
Secondary Brachial artery calcium score Measured by ultrasound of the arteries of the upper limb Day 0
Secondary Presence of arterial rigidity Yes/No, measured by Complior > 10 m/s Day 0
Secondary Disease-associated patient characteristics Age, sex, diabetes, Chronic Renal Disease stage Day 0
Secondary Modification of antihypertensive treatment to maintain systolic tension between 110 and 130 mm Hg Change in antihypertensive treatment following measurement Day 0
See also
  Status Clinical Trial Phase
Completed NCT05990660 - Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery N/A
Recruiting NCT04096547 - Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Completed NCT04024332 - Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects Phase 1
Completed NCT02849964 - Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions N/A
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Completed NCT01462136 - PK Study of ACHN-490 Injection in Renally Impaired Subjects Phase 1
Completed NCT01407874 - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency Phase 2
Completed NCT01172431 - Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency Phase 4
Completed NCT00765830 - Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) Phase 3
Completed NCT01545531 - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance N/A
Completed NCT00770081 - Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) Phase 3
Terminated NCT00338455 - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Phase 2
Completed NCT00159614 - Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment Phase 2
Completed NCT02894385 - Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201) Phase 1
Completed NCT02894905 - A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335 Phase 1
Active, not recruiting NCT04876963 - HOLT-ED: Holter-monitoring in End-stage Renal Disease
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT03235375 - A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects Phase 1
Withdrawn NCT03329612 - Remote Ischemic Preconditioning in ACS Patients N/A
Recruiting NCT02578784 - DEB-after-Cutting Balloon-PTA in Dialysis Fistula Stenosis N/A